Trade

with

Illumina Inc
(NASDAQ: ILMN)
AdChoices
184.82
+5.27
+2.94%
After Hours :
186.79
+1.97
+1.07%

Open

180.82

Previous Close

179.55

Volume (Avg)

2.69M (1.19M)

Day's Range

178.11-188.98

52Wk Range

86.40-188.98

Market Cap.

25.03B

Dividend Rate ( Yield )

-

Beta

0.73

Shares Outstanding

139.40M

P/E Ratio (EPS)

120.48 (1.50)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 1.42B

    • Net Income

    • 125.31M

    • Market Cap.

    • 25.03B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 13.56

    • PEG (Price/Earnings Growth) Ratio

    • 2.47

    • Beta

    • 0.73

    • Forward P/E

    • 56.50

    • Price/Sales

    • 16.75

    • Price/Book Value

    • 23.87

    • Price/Cash flow

    • 52.63

      • EBITDA

      • 296.93M

      • Return on Capital %

      • 7.46

      • Return on Equity %

      • 17.71

      • Return on Assets %

      • 7.46

      • Book Value/Share

      • 7.75

      • Shares Outstanding

      • 139.40M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 175.00

        • Credit Rating

        • BBB-

        • Analysts

        • 5

        • EPS Estimate

        • 2.68

        • Cashflow Estimate

        • 4.21

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 29.30

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -17.20

          • -15.59

          • Net Income

            Q/Q (last year)

          • 29.90

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 19.91

          • 12.51

          • Net Income

            5-Year Annual Average

          • 19.90

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 64.99

            • 52.83

            • Pre-Tax Margin

            • 18.71

            • 15.96

            • Net Profit Margin

            • 13.56

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 67.10

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 16.20

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 11.00

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.90

              • 0.62

              • Current Ratio

              • 2.50

              • 1.97

              • Quick Ratio

              • 2.10

              • 1.16

              • Interest Coverage

              • 8.63

              • 10.47

              • Leverage Ratio

              • 2.81

              • 2.38

              • Book Value/Share

              • 7.75

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 103.09

                • 35.34

                • P/E Ratio 5-Year High

                • 123.60

                • 279.76

                • P/E Ratio 5-Year Low

                • 17.08

                • 148.87

                • Price/Sales Ratio

                • 13.91

                • 3.28

                • Price/Book Value

                • 19.80

                • 4.08

                • Price/Cash Flow Ratio

                • 52.63

                • 16.98

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • 17.71

                        (9.90)

                      • 17.93

                        (21.42)

                      • Return on Assets %

                        (5-Year Average)

                      • 7.46

                        (5.60)

                      • 7.35

                        (9.50)

                      • Return on Capital %

                        (5-Year Average)

                      • 10.77

                        (5.30)

                      • 10.24

                        (13.59)

                      • Income/Employee

                      • 72.87k

                      • 25.65k

                      • Inventory Turnover

                      • 3.27

                      • 2.66

                      • Asset Turnover

                      • 0.55

                      • 0.59

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      134.11M
                      Operating Margin
                      9.44
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      52.63
                      Ownership

                      Institutional Ownership

                      -

                      Top 10 Institutions

                      57.36%

                      Mutual Fund Ownership

                      55.63%

                      Float

                      74.43%

                      5% / Insider Ownership

                      2.32%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • VA CollegeAmerica Growth Fund of America

                      •  

                        5,471,701

                      • -0.18

                      • 3.93

                      • Morgan Stanley Inst Mid Cap Growth Port

                      •  

                        2,599,913

                      • -23.03

                      • 2.02

                      • Harbor Capital Appreciation Fund

                      •  

                        2,397,172

                      • -1.40

                      • 1.72

                      • Vanguard Total Stock Mkt Idx

                      •  

                        2,279,999

                      • 9.39

                      • 1.64

                      • Scottish Mortgage Inv Tr

                      •  

                        2,267,060

                      • 0.00

                      • 1.63

                      • Vanguard Health Care Fund

                      •  

                        2,160,500

                      • 0.00

                      • 1.68

                      • Artisan Mid Cap Fund

                      •  

                        1,787,725

                      • -1.94

                      • 1.28

                      • Columbia Select Large Cap Growth Fund

                      •  

                        1,385,086

                      • 0.00

                      • 0.99

                      • iShares Nasdaq Biotechnology

                      •  

                        1,351,320

                      • -0.69

                      • 0.97

                      • Vanguard Extended Market Index Fund

                      •  

                        1,268,739

                      • -2.32

                      • 0.91

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Baillie Gifford & Co Limited.

                      •  

                        12,741,317

                      • -6.76%

                      • 9.92

                      • Capital Research Global Investors

                      •  

                        9,331,587

                      • -14.87%

                      • 7.27

                      • Fidelity Management and Research Company

                      •  

                        9,113,137

                      • -19.08%

                      • 7.10

                      • Viking Global Investors LP

                      •  

                        7,992,844

                      • -9.85%

                      • 6.22

                      • Morgan Stanley Investment Management Inc

                      •  

                        7,604,375

                      • -18.40%

                      • 5.92

                      • Jennison Associates LLC

                      •  

                        7,510,856

                      • +2.71%

                      • 5.85

                      • Capital World Investors

                      •  

                        6,137,201

                      • -15.31%

                      • 4.81

                      • Vanguard Group, Inc.

                      •  

                        6,113,795

                      • +3.85%

                      • 4.76

                      • Artisan Partners Limited Partnership

                      •  

                        3,619,861

                      • +3.92%

                      • 2.82

                      • BlackRock Fund Advisors

                      •  

                        3,457,953

                      • +0.34%

                      • 2.69

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Medical Instruments & Supplies

                      Type

                      Aggressive Growth

                      Style

                      Large Growth

                      Illumina, Inc. was incorporated in California in April 1998 and reincorporated in Delaware in July 2000. The Company is a developer, manufacturer and marketer of integrated systems for the analysis of genetic variation and biological...more function. Using its proprietary technologies, it provides a line of products and services that currently serve the sequencing, genotyping, and gene expression markets, and it expects to enter the market for molecular diagnostics. The Company’s customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. The Company’s product and service offerings also include leading-edge solutions for single-nucleotide polymorphism genotyping, copy number variation, DNA methylation studies, gen...moree expression profiling, and low-multiplex analysis of DNA, RNA, and protein.The Company’s Life Sciences Business Unit includes all products and services that are mainly related to the research market, namely the product lines based on its sequencing, BeadArray, and real-time PCR technologies.The Diagnostics operating segment focused on opportunities in molecular diagnostics. The Company’s manufacturing operations require a variety of raw materials, electronic and mechanical components, chemical and biochemical materials, and other supplies. The Company's competitors are Affymetrix, Inc.; Agilent Technologies, Inc.; BGI; Luminex Corporation; Pacific Biosciences of California, Inc.; QIAGEN N.V.; Roche Holding AG.; and Thermo Fisher Scientific, Inc., among others. The Company's trademarks includes Illumina®, illuminaDx, BaseSpace®, BeadArray, BeadXpress®, BlueGnome®, cBot, CSPro®, DASL®, DesignStudio, Epicentre®, GAIIx, Genetic Energy, Genome Analyzer, GenomeStudio®, GoldenGate®, HiScan®, HiSeq®, HiSeq X, Infinium®, iSelect®, MiSeq®, MiSeqDx, NeoPrep, NextBio®, Nextera®, NextSeq, SeqMonitor, Solexa®, TruGenome, TruSeq®, TruSight, Understand Your Genome, UYG, VeraCode®, the pumpkin orange color, and the Genetic Energy streaming bases design are certain of its trademarks. The Company’s operations require the use of hazardous materials that subject the Company to a variety of federal, state, and local environmental and safety laws and regulations.lessless

                      Key People

                      Jay T. Flatley

                      CEO/Director

                      Dr. William H. Rastetter,PhD

                      Chairman of the Board/Director

                      Mr. Marc A. Stapley

                      CFO/Senior VP

                      Mr. Michel Bouchard

                      Chief Accounting Officer/Vice President, Divisional

                      Daniel M. Bradbury

                      Director

                      • Illumina Inc

                      • 5200 Illumina Way

                      • San Diego, CA 92122

                      • USA.Map

                      • Phone: +1 858 202-4500

                      • Fax: +1 858 202-4545

                      • illumina.com

                      Incorporated

                      1998

                      Employees

                      3,000

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: